UK’s daily Covid cases rise 49% in a week to above 5,000 for the first time since March, 18 more deaths are announced and the R-rate soars above 1 – but half of adults are now fully vaccinated Department of Health said there were 5,274 positive tests in past 24 hours, highest daily total since… Read More »
Novo Nordisk is back for round two with a new Ozempic dosing regimen. The diabetes specialist resubmitted to the FDA on Friday after a March snub, renewing its bid to compete with Eli Lilly’s already approved higher dose. Novo’s resubmission aims to nab an approval for a once-weekly, 2-mg dose for Ozempic, a GLP-1 drug already approved for weekly dosing at… Read More »
[unable to retrieve full-text content]The weekly supply of the Johnson & Johnson vaccine sent to states will be limited into March, according to senior Biden administration officials. Healthcare
The excitement over the FDA approval of brexanolone (to be marketed as Zulresso) is a good place to start this week’s roundup. Brexanolone is a derivative of the neurosteroid allopregnanolone, and, while Zulpresso was approved specifically for the treatment of postpartum depression, there is considerable research to indicate that the modulation of neurosteroid systems may… Read More »
This week there are a series of articles related to the recommendations issued by the US Preventive Services Task Force (USPSTF) several weeks ago, stating that all pregnant and postpartum women should be evaluated in order to determine risk for depressive illness and recommends that women at increased risk for perinatal depression should be referred… Read More »